Genes associated with persistent lumbar radicular pain; a systematic review by Siri Bjorland et al.
RESEARCH ARTICLE Open Access
Genes associated with persistent lumbar
radicular pain; a systematic review
Siri Bjorland1,2*, Aurora Moen2,3, Elina Schistad2, Johannes Gjerstad3,4 and Cecilie Røe1,2
Abstract
Background: The aim of the present study was to provide an overview of the literature addressing the role of
genetic factors and biomarkers predicting pain recovery in newly diagnosed lumbar radicular pain (LRP) patients.
Methods: The search was performed in Medline OVID, Embase, PsycInfo and Web of Science (2004 to 2015). Only
prospective studies of patients with LRP addressing the role of genetic factors (genetic susceptibility) and pain
biomarkers (proteins in serum) were included. Two independent reviewers extracted the data and assessed
methodological quality.
Results: The search identified 880 citations of which 15 fulfilled the inclusion criteria. Five genetic variants; i.e.,
OPRM1 rs1799971 G allele, COMT rs4680 G allele, MMP1 rs1799750 2G allele, IL1α rs1800587 T allele, IL1RN
rs2234677 A allele, were associated with reduced recovery of LRP. Three biomarkers; i.e., TNFα, IL6 and IFNα,
were associated with persistent LRP.
Conclusion: The present results indicate that several genetic factors and biomarkers may predict slow recovery in LRP.
Still, there is a need for replication of the findings. A stricter use of nomenclature is also highly necessary.
Trial registration: The review is registered PROSPERO 20th of November 2015. Registration number is CRD42015029125.
Keywords: Lumbar radicular pain, Genes, Biomarkers
Background
Low back pain (LBP) has a lifetime prevalence of 70%
[1]. The annual prevalence of lumbar radicular pain
(LRP) in the population is estimated to 2–3% [2, 3].
Hence, LRP, also referred to as “sciatica”, account for
5–10% of the low back pain conditions. However, the dis-
ability is worse and the recovery is slower for LRP than for
other low back pain conditions [3, 4]. Low back disorders
constitute an important source of disability and are among
the most cost-intensive health problems [5].
Development of persistent low back pain and sciatica
may be associated with ergonomic strains, but also
psychosocial aspects. Risk factors such as age, smoking,
body weight, height, occupational load and mental stress
contribute to LRP [2, 3, 6–8]. Clearly, many psychosocial
factors predict poor recovery in LRP [6, 9]. In addition,
genetic variability may influence the risk of a chronic
outcome [10, 11].
LRP is characterized by radiating pain that typically
follows the dermatome of the affected nerve root from
the lumbar or sacral spine [12]. Previous data suggest
that discharges emanating from the dorsal nerve roots
or their ganglions explain the radiating nature of this
form of back disorder [13]. LRP may be induced by
mechanical compression of the nerve root, but also by
the biochemical influence on the neuronal tissues caused
by a local inflammatory process. Moreover, leak of
nucleus pulposus from herniated discs may have many
effects on the nerves inducing histological changes
and increased neuronal excitability. Microvascular changes
close to the dorsal ganglion, spinal nerve roots and spinal
cord is a part of the pathogenesis [14, 15].
Environmental factors including heavy work load is
assumed to contribute to acceleration of degeneration
of the spinal joints and discs, but also genetic factors
are of importance [10]. It has been postulated that
heritability for back pain range from 30 to 45% [16].
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The genetic susceptibility for LBP and LRP may be associ-
ated with genetic variability in genes related to modulation
of nociceptive processing, tissue degeneration and local or
systemic inflammation.
In particular genetic variability important for opioid,
dopaminergic, adrenergic and serotonergic signaling may
affect modulation of nociceptive processing [17–19].
Several previous studies demonstrate a link between genetic
variability in the gene encoding opioid receptor mu 1
(OPRM1) and LRP [20, 21]. Earlier reviews, for example
Diatchenko et al. [22], highlight that genetic factors
related to the enzyme catechol-O-methyltransferase
(COMT) affect cortical pain processing and the risk of
chronic LBP.
Genetic variability in the gene encoding the sodium
ion channel (SCN9A) [23] and the GTP cyclohydrolase 1
(GCH1) [24] gene may affect LRP, indicating that genetic
factors may affect peripheral nerves as well. GCH1 is an
enzyme involved in production of tetrahydrobiopterin
(BH4). BH4 is an essential cofactor for catecholamine,
serotonin and nitric oxide production. Earlier data also
suggest that disc degeneration and the clinical outcome
after sciatica may be associated with the large molecule
collagen type IX alpha 2 (COL9A2) [25]. Thus, previous
data show possible association between genetic markers
and lumbar disc degeneration. However, the relationship
between degenerative changes and persistence of pain is
still controversial [26, 27].
Interestingly, previous findings [28] suggest that patients
with lumbar disc herniation (LDH) have more peripheral
Th17 cells and enhanced IL-17 expression in blood com-
pared with healthy controls. Some studies also indicate an
association between genetic variability in genes encoding
interleukin 1 (IL-1α), interleukin 6 (IL-6) and the human
leukocyte antigen II (HLA II) regarding persistent LRP
[29–33]. Hence, back pain after disc herniation seems
to be associated with activation of the immune system.
From a clinical point of view, slow recovery is a major
challenge in LRP – the disability is worse and the recovery
is slower for LRP than for LBP. Still, previous reviews have
only addressed the relationship between genetic variability
and LBP. In the present study, however, we provide an
overview of the literature addressing genetic factors and
biomarkers predicting pain recovery in LRP patients. The
present review emphasizes that several genetic factors and




The Medline OVID, Embase, PsycInfo and Web of Science
were searched using optimized systematic search strategies
including mesh words with explore and a combination of
words in the title or abstract related to different expressions
of Lumbar radicular pain, Genetic variation and Pain
biomarkers. The main key words for the search in-
cluded “lumbar radicular pain”, “sciatica”, “pain and
lumbar disc herniation”, “pain and lumbar prolapse”
OR “lumbar radiculopathy”, AND “genetic variability”,
“genetic polymorphism”, “allele”, “haplotype”, “micro-
RNA”, “pain biomarker”, “cytokines”, “chemokines”,
“interleukins” OR “interferons”. The search was per-
formed from 2004 up to 12th of January 2015.
Selection of studies
Inclusion criteria were prospective studies, including
patients with lumbar radicular pain, and assessing genetic
factors or pain biomarkers. Exclusion criteria were non
English language, lumbar radicular pain due to tumor, in-
fection or systemic disorders.
Procedure
Based on screening of the titles and abstracts eligible
articles for full text reading by two of the authors were
identified.
Assessing the quality of the studies
A checklist based on Sanderson et al. [34], QATSO
(Quality Assessment Tool for Systematic Reviews of
Observational studies) [35] and the STROBE statement
guidelines (Strengthening the Reporting of Observational
Studies in Epidemiology) [36] was used. The checklist
compromised seven criteria namely: external validity, sam-
ple size, description of sample, follow up rate, appropriate
reporting of outcome, adjustment for confounding factors
(No = not adjusted for any covariates. Yes = adjusted) and
correction for multiple testing. The assessments of the
two reviewers were compared. If disagreement a final
evaluation of the paper was performed.
Results
The systematic search identified 880 relevant publications,
of which 791 were excluded after screening of titles and
abstracts. Thus, 89 studies were found eligible, but after
full-text screening only 15 publications met the inclusion
criteria (Fig. 1).
Methodological quality
A summary of methodological quality is shown in Table 1.
External validity found to be satisfactory in 11 of the 15
included studies and number of cases >100 in 10 of the
studies. The studies comprise a total of 872 LRP patients
and mean age ranged from 41 to 47 years. Seven of the
studies emanates from the same patient population that
affect the total number of patients included (Table 1).
Although all the studies provided a short description of
the sample, several shortcomings in this description were
identified. Just one study, Karppinen et al. [29], included
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BMI and work load in the analyzes. Moreover, Gebhardt
et al. [37] controlled for smoking and BMI. In only 6
studies the data were evaluated after correction for their
multiple testing.
Assessment and definition of pain recovery
All but one study reported VAS (Visual analog scale) as
assessment tool for pain. Tegeder et al. [24] did not
describe how pain was measured, but provide us the
z-score from several time points to express the develop-
ment in pain intensity over time. Detailed information
about pain intensity was not present in most of the in-
cluded studies. Moreover, we found a variety of different
pain descriptions/locations and procedures for pain testing.
In two studies, the pain score was based on pain during
activity, in two of the studies at rest, whereas in the rest of
the studies this was not clearly described. Pain duration at
baseline were described in five studies where two reported
duration ≥3 months, one study <3 months and the two
last both ≥3 and <3 months.
Even if the follow up time was 12 months or more in
12 of the studies, the presentation of the development of
pain over time was not clear. Gebhardt et al. [37] measured
pain at 12 time points and gave a detailed description of
how high-sensitive C-reactive protein (hsCRP) declined
corresponding to decreased pain first 3 weeks, but did not
emphasized what happened after the subacute phase.
Pain recovery was described in 4 of the studies. Andrade
et al. [38, 39] used >20% reduction in VAS while Rut et al.
[40] and Takeuchi et al. [41] used >50% reduction in VAS
between baseline and follow to define recovery. Specific
description of change in pain state during the follow up
period was reported in just two of the studies. Both Olsen
et al. [20] and Schistad et al. [30, 42] described a signifi-
cant decrease in pain the first year after herniation.
Genetic variability and pain recovery
In 9 of the studies the association between genetic vari-
ability and LRP were studied (Table 2). The roles of 20
genetic polymorphisms were addressed. Only 1 study
Fig. 1 Selection process
Table 1 Methodological quality assessment of included studies
Study External validity Sources of Bias Statistics
Findings can
be generalised
Sample size cases Description
sample








Andrade et al. (2013) [39] No n = 10 Yes 100% Yes No No
Andrade et al. (2011) [38] No n = 10 Yes 100% Yes No No
Gebhardt et al. (2006) [37] Yes n = 31 Yes 88% Yes Yes Yes
Hasvik et al. (2014) [21] Yes n = 118a Yes 95% No Yes Yes
Jacobsen et al. (2013) [44] Yes n = 260a Yes 91% Yes Yes Yes
Jacobsen et al. (2012) [43] Yes n = 258a Yes 89% Yes Yes Yes
Karppinen et al. (2008) [29] Yes n = 153 Yes 97% Yes No No
Moen et al. (2014) [31] Yes n = 252a Yes 91% No Yes Yes
Olsen et al. (2012) [20] Yes n = 258a Yes 92% Yes Yes Yes
Rut et al. (2014) [40] Yes n = 176 Yes 100% Yes Yes No
Schistad et al. (2014) [42] Yes n = 108a Yes 90% Yes Yes No
Schistad et al. (2014) [30] Yes n = 121a Yes 91% No No No
Scuderi et al. (2009) [45] No n = 47 Yes 100% Yes No No
Takeuchi et al. (2007) [41] No n = 27 Yes 100% Yes Yes No
Tegeder et al. (2006) [24] Yes n = 168 Yes 88% Yes Yes NA
NA, not applicable, ND, not described
aemanates from the same patient population
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addressed the relationship between genetic variability
and tissue degeneration seen on MRI.
Olsen et al. [20] and Hasvik et al. [21] demonstrated that
a genetic variant, OPRMI rs1799971 SNP, in the gene en-
coding OPRM1 receptor is associated with both pain and
subjective health in LRP patients. The OPRM1 rs1799971
G allele increased the pain score in women, but reduced
the pain score in men. Thus, the data revealed a signifi-
cant interaction between sex and OPRM1 genotype
regarding the pain intensity.
Jacobsen et al. [43] showed that the COMT rs4680
SNP affects pain recovery after disk herniation. In both
men and women, carriers of COMT rs4680 2G alleles
had more pain than carriers of two A alleles at 6 months
after disc herniation. Conversely, Rut et al. [40] reported
that carriers of two COMT rs4680 G alleles may be as-
sociated with significant positive improvement in pain
recovery one year after surgery.
Jacobsen et al. [44] addressed the relationship between
MMP1 rs1799750 SNP and tissue degeneration. The
data indicated that the MMP1 rs1799750, in the gene
encoding the MMP1 enzyme, may affect the long-term
outcome in disc herniation patients. Carriers of two
MMP1 rs1799750 2G alleles had a reduced pain recov-
ery rate, but not increased MRI disc changes.
Moen et al. [31] and Schistad et al. [30, 42] found in-
creased risk of persistent pain in carriers of the IL1α
rs1800587 T allele. Moreover, Karppinen et al. [29] dem-
onstrated a significant association between the IL-6 haplo-
type rs1800797 G/rs1800796 C/rs1800795 C/rs13306435
A and days of leg pain 3 years after disc herniation in men
with high physical work load. Finally, Tegeder et al. [24]
showed that the GTP cyclohydorlase (GSCH1) haplotype
rs8007267 A/rs3783641 T/rs8007201 C/rs752688 A could
be protective and be associated with less pain following
discectomy.
Six of the studies emanates from the same patient
population (Table 1). None of these association studies
included data on protein expression.
Biomarkers and pain recovery
Six studies presented data on biomarkers linked to pain
recovery (Table 3). As many as 28 biomarkers have been
assessed: IL1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL- 10,
Table 2 Genetic variability and pain recovery
Gene rs number Base substitution Position in DNA Amino acid substitution Reference Result
OPRM1 rs1799971 A→G 118 Asn40Asp Hasvik et al. (2014) [21] ↑(W) ↓(M)
rs1799971 A→ G 118 Asn40Asp Olsen et al. (2012) [20] ↑(W) ↓(M)
COMT rs4680 A→ G 472 Val158Met Jacobsen (2012) [43] ↑
rs4680 A→ G 158 Val 158Met Rut et al. (2014) [40] ↓
rs6269 G→ A −98 – –
rs4633 T→ C 186 – ↓
rs4818 G→ C 408 – –
MMP1 rs 1799750 1G allele→ 2G allele −1719 – Jacobsen (2013) [44] ↑
IL1A rs1800587 C→ T −949 – Moen et al. (2014) [31] ↑
rs1800587 C→ T −949 – Schistad et al. (2014) [30] ↑
IL1B rs1143627 T→ C −118 – Moen et al. (2014) [31] –
IL1RN rs2234677 G→ A −87 – ↑
IL-6 rs1800797
rs1800796
A→ G −661 – Karppinen et al. (2008) [29] - (Haplotype GGGA)
G→ C −636 –
rs1800795 G→ C −237 –
rs13306435 T→ A 486 Asp162Glu
GCH1 rs8007267 G→ A −9610 – Tegeder et al. (2006) [24] ↓ (Haplotype ATCA)
rs3783641 A→ T 343 + 8900 –
rs8007201 T→ C –
rs752688 G→ A 509 + 1551
627–708
–
The rs number refers to a specific SNP and rs stands for Reference SNP cluster ID, created by National Center for Biotechnology Information (NCBI) (Ref.:
http://www.ncbi.nlm.nih.gov/). Base substitution refers to replacement of one base with another in DNA. Position on DNA based on information from
NCBI. Only two of our SNP causes a direct amino acid substitution. A change of nucleotide in the exon is a prerequisite for change in amino acid. A
replacement of nucleotide in the intron does not cause such a substitution but may have a role in the transcription process. Polymorphism located in the
promotor part of the gene is expressed by adding minus prior to the position on the DNA
↑ (positive association with poor recovery), ↓ (negative association with poor recovery), - (no change in amino acid), - (no association with poor recovery), W
(Women), M (Men)
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IL-12, IL-13, IL-17, G-CSF, GM-CSF, MCP-1b, MIP-1b,
TNFα, TNF R1, TNF R2, CGRP1, Galanin, Neuropep-
tides4, SubstP. Most of the biomarkers examined are
members of the cytokine family, but also the role of
some neuropeptides is among the studied molecules. In
addition low levels of the C-reactive protein (hsCRP)
were assessed in the study by Gebardt et al. 2006 [37].
Andrade et al. [39] was unable to detect any link
between Il-6 and pain recovery while Schistad et al.
[30, 42] demonstrated from the results that high level of
IL-6 correlate with less favorable pain recovery 1 year after
disk herniation. Regarding recovery, Andrade et al. [38]
and Scuderi et al. [45] found a link to tissue and CSF level
of TNFα at one year and tissue IFNα level at 3 month –
whereas Takeuchi et al. [41] found that plasma level of the
neuropeptide CGRP was associated with the extent of
sciatica. In acute lumbosciatic patient, hsCRP declined
with decreased pain the first 3 weeks after disc herniation,
but no clear relationship between pain and level of hsCRP
was observed after that (Gebhardt et al. 2006 [37]). Specific
results from the studies assessing biomarkers and pain
recovery are listed in Table 3.
Discussion
In the present review, we identified nine studies addressing
the relationship between genetic polymorphism and LRP.
The data analyzed in these studies were limited to eleven
DNA base substitutions. In all these studies, polymor-
phisms of genes encoding proteins expected to affect
the phenotype were studied [46]. Some of the SNPs
were located in the promoter region, whereas others
were located in the coding regions of the genes.
Two studies reported a positive association between
the OPRM1 SNP rs179971 and poor recovery of pain in
women with LRP [20, 21]. These data support the previous
observation that some individuals, in particular in females,
carrying the ORPM1 G allele have increased pain sensitivity
[47, 48]. OPRM1 is crucial for processing and modulation
of pain. Moreover, several studies addressed the association
between COMT SNP rs4680 G allele and pain. This en-
zyme metabolizes catecholamines and thus modulates
adrenergic, noradrenergic and dopaminergic signaling
in the CNS as well as in the peripheral tissue. However,
while Jacobsen et al. found a positive correlation between
the COMT rs4680 G allele and long lasting pain, Rut et al.
reported that the same SNP may be associated with better
clinical outcome [40, 43].
Although the data may be debated, most experimental
studies support a positive correlation between the COMT
haplotype rs4680 G, rs6269 A, rs4633 C, rs4818 C and pain
hypersensitivity [49]. Moreover, several of these COMT
SNPs may be associated with increased postoperative pain.
For example, the COMT haplotype rs4680 G, rs6269 A,
rs4633 C, rs4818 C is associated with slower recovery
after surgical treatment for lumbar degenerative disc
disease [50].
Only one study addressed the relationship between
genetic variability, tissue degeneration and persistent
pain [44]. Previous data suggest that the enzyme MMP
influences tissue degradation or inflammation [51]. Sur-
prisingly, however, no relationship between the MMP1
SNP rs1799750 and disc degeneration shown on MRI
was observed in the systematic search performed for this
review. Still, the study of Jacobsen et al. [44] showed that
the MMP1 SNP rs1799750, i.e., the 2G allele insert, may
be associated with poor pain recovery after lumbar disc
herniation. Previous studies show that other painful de-
generative inflammatory conditions may be associated
with the MMP1 SNP rs1799750 2G allele [52, 53].
Several lines of evidence suggest that genetic variability
in genes encoding inflammatory cytokines may be associ-
ated with persistent LBP [16]. The present review shows
data that the IL1α rs1800587 T allele and the IL6 haplo-
type rs180077 G, rs1800796 C, rs1800795 C, rs13306435
A may be associated with slower recovery in LRP patients
[29–31]. Moreover, data exists that the rare allele of the
gene encoding the GTP cyclohydrolase, could be asso-
ciated with reduced pain following discectomy in LRP
patients [24]. However, more recent reports questions
these data [54].
Six studies in the present review show correlations be-
tween protein levels and recovery of pain [37–39, 41, 42, 45].
However, only IL-6, TNFα and IFNα seem to be associ-
ated with persistence of LRP. Schistad et al. [30, 42]
showed that higher serum level of IL-6 predicts a less
favorable clinical outcome. Moreover, Scuderi et al. [45]
and Andrade et al. [38] showed that TNFα and IFNα
may be associated with persistent LRP. In addition, pre-
vious studies suggest a correlation between TNFα and
recovery of pain in chronic LBP and lumbar radiculopathy
patients [55, 56].
Development of persistent pain is multifactorial. It is
now well established that psychosocial factors, such as
depressive mood, distress and somatization, may contribute
to chronic LRP [57]. Together with individual factors as
gender, age, smoke, obesity and education level, genetic
predisposition may be crucial prognostic factors in LBP
patients as well as LRP patients [6, 57].
Strength and limitation
To our knowledge, this is the first paper attempting to
provide an overview over genetic variants linked to the
development of persistence LRP. Still, many of the find-
ings, including the role of the GTP cyclohydrolase, are
controversial and need to be replicated [54]. In addition
few researchers present genetic data together with changes
in protein expression. In further studies this knowledge
gap need to be highlighted.
Bjorland et al. BMC Musculoskeletal Disorders  (2016) 17:500 Page 7 of 10
Therefore, the interpretations of the data, but also the
heterogeneity in the nomenclature, might be challenging.
In the present review we have listed the genetic variants
by number, base substitution, position on DNA and if
applicable amino acid substitution. Position of base re-
placement refers to position found in National Center
for Biotechnology (NCBI). The majority of the nucleotide
replacements listed is located in the intron or promotor
region. Only two of the SNPs cause amino acid sub-
stitution. Regarding the interpretation of the data, the
link between the genetic variability, protein expression
and function is therefore definitely challenging.
External validity in all but one of the genetic associ-
ation studies is fair. The sample size was >100 patients
in nine studies, however, as many as six of the samples
emanate from the same cohort, and the methodological
quality of the studies may still be debated. A bias towards
only positive findings being published cannot be excluded.
Moreover, the external validity is poor in the six studies
about biomarkers – and in only two studies correction for
multiple testing was performed. The strength of this
review, however, is the optimized systematic search in
several databases and the strict inclusion criteria.
Unfortunately, the studies were too few and too heteroge-
neous to perform meta-analyses, and many of the studies
emanate from the same cohort. Further on, GWAS would
shed light on other genetic factors related to the same phe-
nomena. Unfortunately, however, most clinical studies do
not have enough statistical strength for GWAS. This may
be a major challenge in clinical research. None of the
included studies were GWAS. Moreover, no studies
addressed the interaction between environmental factors
and genetic markers. An extensive systematic review by
Eskola et al. 2012 regarding LBP and genetics evaluated that
the credibility of reported genetic associations were mostly
weak including four of our candidate genes; IL1α, IL1β,
IL1RN, MMP1. Finally, each SNP in this review explained
just about 1% of the variance. Previous studies show that
the explained variance of the SNPs in general is rather
low – even for inherited characteristics like human
height [58]. Thus, the low explained variance in the
present studies underscores the complex mechanisms
and multifactorial nature of LRP. Furthermore, the causal
relationship between genetic factors and LRP remains to be
examined. The clinical value of this review can be ques-
tioned but the presented findings may be of importance for
better understanding pain mechanism and further research.
Conclusion
This systematic review suggests that several genetic
factors involved in pain perception, inflammation and
tissue degeneration may be linked to poor recovery in
LRP patients. Further, serum levels of the IL-6, IFNα
and TNFα proteins correlate with persistent LRP. The
existing literature in this review revealed, however, that
many articles are based on the same cohorts; hence the
results were generally not replicated in different cohorts.
Relatively few candidate genes were examined and the
explained variance relatively low. Hence, broader panels of
genes and replication of findings across pain cohorts are
needed in order to implement these findings in diagnostic
procedures and treatment.
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